Mario Castello/Corbis/VCG
- Eli Lilly just debuted its powerful new weight-loss drug, Zepbound.
- Zepbound is about 20% cheaper than competing drug Wegovy, which may help some Americans save money.
- Still, at over $1,000 a month, the drug is unaffordable for many.
Eli Lilly, the most valuable pharma company in the world, has decided to go cheap. (Well, sort of.)
On Wednesday, when the $588 billion company debuted its powerful new weight loss drug, Zepbound, it did something unusual in the pharmaceutical world: It undercut the competition, pricing the shot almost 20% lower than Novo Nordisk's Wegovy.